Joan Montero
@joanmontero.bsky.social
Associate Professor at University of Barcelona (Campus Clínic). Leading the Cell death, senescence and cancer precision medicine group. ICREA Acadèmia awardee. Former IBEC/DFCI/HMS. Board member of the SfPM. www.themonterolab.com
Congratulations @senescel.org for this great meeting! Total success! Dr. Clara Alcon presented our work focused on TIS-mediated resistance, and how to detect it using BH3 profiling and overcome it targeting anti-apoptotic proteins. Can’t wait for the next meeting!
November 8, 2025 at 8:50 AM
Congratulations @senescel.org for this great meeting! Total success! Dr. Clara Alcon presented our work focused on TIS-mediated resistance, and how to detect it using BH3 profiling and overcome it targeting anti-apoptotic proteins. Can’t wait for the next meeting!
Reposted by Joan Montero
🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM
www.sfpm.io/seminars
www.sfpm.io/seminars
Seminars | SFPM
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
www.sfpm.io
October 8, 2025 at 11:10 AM
🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM
www.sfpm.io/seminars
www.sfpm.io/seminars
Reposted by Joan Montero
#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques.
🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
Aconsegueixen revertir l’alzheimer en ratolins amb l'ús de nanopartícules - Institute for Bioengineering of Catalonia
Un equip internacional codirigit per l'Institut de Bioenginyeria de Catalunya (IBEC) i l'Hospital West China de la Universitat de Sichuan (WCHSU) va poder revertir l'Alzheimer en ratolins després de n...
ibecbarcelona.eu
October 7, 2025 at 1:13 PM
#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques.
🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!
We want to congratulate our President, Dr. Tony Letai, on his appointment as Director of the NCI. This announcement marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine 🧵
www.nih.gov/news-events/...
www.nih.gov/news-events/...
Secretary Kennedy Swears in Dr. Anthony Letai as Director of the National Cancer Institute
Dr. Letai will serve as NCI’s 18th director.
www.nih.gov
September 30, 2025 at 6:09 AM
Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!
A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam
www.youtube.com/watch?v=CqLC...
www.youtube.com/watch?v=CqLC...
How functional precision medicine could be the future of cancer care | Dr. Diana Azzam | TEDxMiami
YouTube video by TEDx Talks
www.youtube.com
August 26, 2025 at 11:04 AM
A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam
www.youtube.com/watch?v=CqLC...
www.youtube.com/watch?v=CqLC...
Delighted to see good research highlighted on TV @som.3cat.cat
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Càncer de mama: identifiquen les cèl·lules que actuen com a llavors de la metàstasi
Investigadors de l'Hospital del Mar vinculen per primer cop una proteïna a la metàstasi en el càncer de mama i obren la porta a tractaments preventius
www.3cat.cat
July 11, 2025 at 1:16 PM
Delighted to see good research highlighted on TV @som.3cat.cat
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Reposted by Joan Montero
This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
July 10, 2025 at 7:59 AM
This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it!
www.sfpm.io/seminars
www.sfpm.io/seminars
Seminars | SFPM
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
www.sfpm.io
July 2, 2025 at 3:05 PM
✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it!
www.sfpm.io/seminars
www.sfpm.io/seminars
🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer
Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss t...
www.nature.com
June 27, 2025 at 2:41 PM
🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Joan Montero
Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...
April 28, 2025 at 6:30 PM
Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...
Quote of the day: “If you think research is expensive, try disease.” Mary Lasker
April 15, 2025 at 10:14 AM
Quote of the day: “If you think research is expensive, try disease.” Mary Lasker
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here:
web.ub.edu/en/web/actua...
web.ub.edu/en/web/actua...
New advances in the fight against the most common form of lung cancer
web.ub.edu
April 9, 2025 at 9:37 AM
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here:
web.ub.edu/en/web/actua...
web.ub.edu/en/web/actua...
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer
Cell Death & Disease - Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer
rdcu.be
March 21, 2025 at 8:52 AM
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social
www.sfpm.io/seminars
www.sfpm.io/seminars
March 11, 2025 at 11:14 AM
Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social
www.sfpm.io/seminars
www.sfpm.io/seminars
Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!
March 8, 2025 at 4:36 PM
Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!
🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com
Home | Montero Lab
The Montero Lab at the University of Barcelona's Department of Biomedical Sciences is dedicated to exploring the biology of cancer metastasis.
themonterolab.com
February 13, 2025 at 10:40 AM
🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com
Reposted by Joan Montero
Papers on cell death from January 2025
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
ApoList – January 2025
Caspases TIR signaling activates caspase-like immunity in bacteria – François Rousset, Ilya Osterman, Tali Scherf, Alla H. Falkovich, Azita Leavitt, Gil Amitai, Sapir Shir, Sergey Malitsky, M…
celldeath.wordpress.com
February 4, 2025 at 5:31 PM
Papers on cell death from January 2025
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social
February 4, 2025 at 10:30 AM
On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social
Reposted by Joan Montero
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial
Key PointsBlast-specific ex vivo venetoclax sensitivity correlated strongly with treatment responses and predicted longer survival.VenEx trial showed that
ashpublications.org
January 29, 2025 at 6:45 AM
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Reposted by Joan Montero
#RecercaUB | 🔬 Un estudi liderat per la #UniBarcelona descriu un mecanisme per eliminar les cèl·lules perjudicials originades per tractaments oncològics
📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.
👉 web.ub.edu/web/actualit...
📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.
👉 web.ub.edu/web/actualit...
Descriuen un mecanisme per poder eliminar les cèl·lules perjudicials originades per tractaments oncològics
Després de tractar un tumor amb quimioteràpia i radioteràpia, es poden originar unes cèl·lules que es coneixen com a senescents. Són cèl·lules que no es divideixen, estan involucrades en el procés d’envelliment i són resistents a la mort cel·lular, però encara són actives metabòlicament en el cos humà. Quan s’hi acumulen, poden posar en risc la recuperació dels pacients. Ara, una recerca liderada per la UB descriu per primer cop un mecanisme molecular que podria impulsar el disseny d’estratègies per eliminar les cèl·lules senescents en els pacients oncològics.
web.ub.edu
January 22, 2025 at 1:49 PM
#RecercaUB | 🔬 Un estudi liderat per la #UniBarcelona descriu un mecanisme per eliminar les cèl·lules perjudicials originades per tractaments oncològics
📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.
👉 web.ub.edu/web/actualit...
📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.
👉 web.ub.edu/web/actualit...
Thrilled to receive the prestigious ICREA Acadèmia award! A heartfelt thank you to everyone at @ub.edu & ICREA - Institució Catalana de Recerca i Estudis Avançats who made this possible.
#RecercaUB | 🙌 El programa ICREA Acadèmia distingeix 1️⃣6️⃣ membres de la #UniBarcelona, que esdevé la institució que més ajuts rep en aquesta convocatòria.
🔬 Cadascun obtindrà 40.000 euros anuals durant 5 anys per impulsar la seva carrera investigadora.
👏 L’enhorabona!
👉 web.ub.edu/web/actualit...
🔬 Cadascun obtindrà 40.000 euros anuals durant 5 anys per impulsar la seva carrera investigadora.
👏 L’enhorabona!
👉 web.ub.edu/web/actualit...
January 14, 2025 at 2:40 PM
Thrilled to receive the prestigious ICREA Acadèmia award! A heartfelt thank you to everyone at @ub.edu & ICREA - Institució Catalana de Recerca i Estudis Avançats who made this possible.
Proud to share three papers from our lab rdcu.be/d2hUm @ub.edu , Letai lab rdcu.be/d5rb3, and R. Bernards rdcu.be/d5rjW all showing predictable mitochondrial control of senescent cell death, using BH3 profiling as a biomarker for senolytic therapy.
HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells
Cell Death & Differentiation - HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells
rdcu.be
January 7, 2025 at 3:25 PM
Proud to share three papers from our lab rdcu.be/d2hUm @ub.edu , Letai lab rdcu.be/d5rb3, and R. Bernards rdcu.be/d5rjW all showing predictable mitochondrial control of senescent cell death, using BH3 profiling as a biomarker for senolytic therapy.
Reposted by Joan Montero
Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year!
Drs. Damle and Pillarisetty from @fredhutch.bsky.social will discuss tumor slice cultures as a window into the human TME.
Info to join here: www.sfpm.io/seminars
Drs. Damle and Pillarisetty from @fredhutch.bsky.social will discuss tumor slice cultures as a window into the human TME.
Info to join here: www.sfpm.io/seminars
Seminars | SFPM
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
www.sfpm.io
December 10, 2024 at 3:55 PM
Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year!
Drs. Damle and Pillarisetty from @fredhutch.bsky.social will discuss tumor slice cultures as a window into the human TME.
Info to join here: www.sfpm.io/seminars
Drs. Damle and Pillarisetty from @fredhutch.bsky.social will discuss tumor slice cultures as a window into the human TME.
Info to join here: www.sfpm.io/seminars
Reposted by Joan Montero
We're looking for a hard working and ambitious postdoc to join our lab studying cell death in cancer, development, toxicology, neurodegeneration and beyond! We strive to maintain a diverse, inclusive and collaborative work environment.
Apply now at sarosieklab.org!
Apply now at sarosieklab.org!
Kristopher Sarosiek's Faculty Website
Researching Cell Death
sarosieklab.org
November 21, 2024 at 10:50 AM
We're looking for a hard working and ambitious postdoc to join our lab studying cell death in cancer, development, toxicology, neurodegeneration and beyond! We strive to maintain a diverse, inclusive and collaborative work environment.
Apply now at sarosieklab.org!
Apply now at sarosieklab.org!